SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-065635
Filing Date
2019-03-06
Accepted
2019-03-06 16:33:03
Documents
4
Period of Report
2019-03-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d663426d8k.htm 8-K 16955
2 EX-1.1 d663426dex11.htm EX-1.1 223720
3 EX-5.1 d663426dex51.htm EX-5.1 8405
4 GRAPHIC g663426page04.jpg GRAPHIC 10341
  Complete submission text file 0001193125-19-065635.txt   264756
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 19662912
SIC: 2834 Pharmaceutical Preparations